Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis
Authors:
Open Access
- 20 November 2020
- journal article
- research article
- Published by Springer Nature in BMC Surgery
- Vol. 20 (1) , 1-10
Abstract
Background: Adult hemiliver transplantation (AHLT) is an important approach given the current shortage of donor livers. However, the suitability of AHLT versus adult whole liver transplantation (AWLT) for recipients with high Model for End-Stage Liver Disease (MELD) scores remains controversial.Methods: We divided patients undergoing AHLT and AWLT into subgroups according to their MELD scores (≥ 30: AHLT, n = 35; AWLT, n = 88; and < 30: AHLT, n = 323; AWLT, n = 323). Patients were matched by demographic data and perioperative conditions according to propensity scores. A cut-off value of 30 for MELD scores was determined by comparing the overall survival data of 735 cases of nontumor liver transplantation.Results: Among patients with an MELD score ≥ 30 and < 30, AHLT was found to be associated with increased warm ischemia time, operative time, hospitalization time, and intraoperative blood loss compared with AWLT (P < 0.05). In the MELD ≥ 30 group, although the 5-year survival rate was significantly higher for AWLT than for AHLT (P = 0.037), there was no significant difference between AWLT and AHLT in the MELD < 30 group (P = 0.832); however, we did not observe a significant increase in specific complications following AHLT among patients with a high MELD score (≥ 30). Among these patients, the incidence of complications classified as Clavien-Dindo grade III or above was significantly higher in patients undergoing AHLT than in those undergoing AWLT (25.7% vs. 11.4%,P = 0.047). For the MELD < 30 group, there was no significant difference in the incidence of complications classified as Clavien-Dindo grade III or above for patients undergoing AHLT or AWLT.Conclusion: In patients with an MELD score < 30, AHLT can achieve rates of mortality and overall survival comparable to AWLT. In those with an MELD score ≥ 30, the prognosis and incidence of complications classified as Clavien-Dindo III or above are significantly worse for AHLT than for AWLT; therefore, we may need to be more cautious regarding the conclusion that patients with a high MELD score can safely undergo AHLT.Keywords
Funding Information
- National Major Science and Technology Projects of China (2017ZX10203205-001-004, No. 2017ZX10203205-005-002)
- 1.3.5 project for disiplines of excellence, West China Hospital, Sichuan University (No. ZY2017308)
This publication has 45 references indexed in Scilit:
- A pilot programme of organ donation after cardiac death in ChinaThe Lancet, 2012
- Impact of MELD on Waitlist Outcome of Retransplant CandidatesAmerican Journal of Transplantation, 2010
- Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factorsLiver Transplantation, 2010
- Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipientsCritical Care, 2010
- Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costsLiver Transplantation, 2010
- Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantationBMC Gastroenterology, 2009
- Recipient Morbidity After Living and Deceased Donor Liver Transplantation: Findings from the A2ALL Retrospective Cohort StudyAmerican Journal of Transplantation, 2008
- Combination of Extended Donor Criteria and Changes in the Model for End-Stage Liver Disease Score Predict Patient Survival and Primary Dysfunction in Liver Transplantation: A Retrospective AnalysisTransplantation, 2007
- Pretransplant MELD score and post liver transplantation survival in the UK and IrelandLiver Transplantation, 2004
- Living donor liver transplantation: Summary of a conference at The National Institutes of HealthLiver Transplantation, 2002